CASP3 and familial pancreatic carcinoma: The research findings suggest that TPL treatment led to a notable upsurge in Annexin V expression, intensified TUNEL staining, heightened caspase-3 activity, and the release of mitochondrial cytochrome c in both pancreatic cancer MiaPaCa-2 and PANC-1 cells [101].